Business
Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the completion of its previously announced acquisition of select clinical testing assets of Fresenius Medical Care's wholly owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the United States. With this acquisition, Quest will be positioned to provide dialysis-related clinical testing to independent dialysis clinics previously served by Spectra Labor
About this update from Fresenius Medical Care Ag
[{"type":"text","content":"SECAUCUS, N.J., Aug. 5, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the completion of its previously announced acquisition of select clinical testing assets of Fresenius Medical Care's wholly owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the United States. With this acquisition, Quest will be positioned to provide dialysis-related clinical testing to independent dialysis clinics previously served by Spectra Laboratories. Quest also expects to complete the acquisition of select dialysis-related water testing assets by the end of 2025.","length":682,"tagName":"p"},{"type":"image","alt":"Quest Diagnostics Incorporated logo. (PRNewsFoto/Quest Diagnostics Incorporated)","displaySize":"","headline":null,"caption":"Quest Diagnostics Incorporated logo. (PRNewsFoto/Quest Diagnostics Incorporated)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":190,"url":"https://media.zenfs.com/en/prnewswire.com/328ba769d21514205fa2226e0dacf99b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/10t_J0fsHk4Z61kiPTCtrg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTMzNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/328ba769d21514205fa2226e0dacf99b","width":400,"height":190}},"href":"https://mma.prnewswire.com/media/200883/quest_diagnostics_incorporated_logo_logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"In addition, under a separate, previously announced laboratory services agreement, Quest later this month will begin to provide comprehensive dialysis-related laboratory services for dialysis centers operated by Fresenius Medical Care in the United States, which serve approximately 200,000 patients annually. The transition of services is expected to increase over the next several months and to be completed by early 2026.","length":424,"tagName":"p"},{"type":"text","content":"The arrangement will allow providers and patients at dialysis clinics to benefit from Quest's clinical leadership and diagnostic innovation in chronic kidney disease services. Multiple Quest laboratories across the U.S. will provide testing for nearby dialysis clinics, reducing transportation time and speeding results reporting for some test services. In addition, Quest expects to...